Related Experiment Video
Updated: Oct 29, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Morphologic and Molecular Findings in Myxoid Hepatic Adenomas
Daniel J Rowan1, Saba Yasir1, Zongming E Chen1
1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Myxoid hepatic adenomas, a rare liver tumor subtype, frequently undergo malignant transformation. These tumors are characterized by HNF1A mutations and alterations in the protein kinase A (PKA) pathway.
Area of Science:
- Hepatology
- Oncology
- Molecular Pathology
Background:
- Myxoid hepatic adenomas (MHAs) are rare hepatic adenoma subtypes.
- Characterized by extracellular myxoid material deposition between hepatic plates.
Purpose of the Study:
- To investigate the clinicopathological and molecular features of myxoid hepatic adenomas.
- To assess the malignant transformation potential of MHAs.
Main Methods:
- Retrospective analysis of 9 MHA cases.
- Histopathological examination and molecular profiling (gene mutation analysis).
Main Results:
- MHAs occurred in middle-aged adults (average 59 years) and showed a high rate of malignant transformation (5/9 cases).
- Molecularly, MHAs exhibited HNF1A inactivating mutations with loss of LFABP protein expression.
- Recurrent mutations were identified in GNAS, CDKN1B, and RNF123, genes involved in the protein kinase A (PKA) pathway.
Conclusions:
- Myxoid hepatic adenomas are rare tumors in older individuals with a significant risk of malignant transformation.
- Combined inactivation of HNF1A and mutations within the PKA pathway are key molecular drivers of MHAs.
More Related Videos
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024